Pea protein isolate: effects on blood amino acids after consumption

Effect of acute pea protein isolate consumption on plasma amino acid profile in healthy individuals: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-3r5k63t

Enrollment

Registered

2026-03-27

Start date

2026-05-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers Metabolism

Interventions

This is a randomized, controlled, crossover, double-blind clinical trial conducted in accordance with the recommendations of the Consolidated Standards of Reporting Trials (CONSORT). The study will in

Eligibility

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: Healthy adult and elderly individuals (age =19 years). Only individuals who agree to participate in the study by signing the Informed consent form will be included

Exclusion criteria

Exclusion criteria: Individuals with any inflammatory process; pulmonary; cardiovascular; degenerative; neurological; or rheumatic diseases; cancer; diabetes mellitus; smokers; alcoholics; pregnant women; those using medication or any type of dietary supplement in the last 4 weeks prior to data collection or those with allergies or intolerance to the intervention will be excluded

Design outcomes

Primary

Measure	Time frame
An increase in plasma amino acid levels over time is expected following the consumption of pea protein isolate, with a kinetic profile similar to that observed for whey protein isolate	—

Secondary

Measure	Time frame
No secondary outcomes are expected	—

Countries

Contacts

Public ContactSuellen Guesser Homem

Universidade Federal de Santa Catarina

suellenguesser@gmail.com+55(48)99994-5438

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Apr 4, 2026